Back
ESC Premium Access

Hospital resource utilization, cost and inpatient mortality associated with hospitalizations for major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Session: Poster session 3 - Anticoagulation in atrial fibrillation II
Topic: Atrial fibrillation (AF)
Speaker: Doctor S. Deitelzweig (New Orleans, US)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Doctor Steven Deitelzweig

Ochsner Medical Center, New Orleans (United States of America)
7 presentations
0 follower

22 more presentations in this session

Is Aspirin monotherapy effective for stroke prevention in the real world? A UK cohort study evaluating the incidence of stroke in the absence of anticoagulation in atrial fibrillation (AF)

Speaker: Doctor E. Ridha (London, GB)

Access
Abstract
Slides
Thumbnail

Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Access
Abstract
Slides
Thumbnail

In-hospital mortality, length of stay and costs of treating atrial fibrillation or flutter patients admitted for intracranial hemorrhage

Speaker: Doctor E. Nguyen (Storrs, US)

Access
Abstract
Slides
Thumbnail

One-year permeability rate of left atrial appendage closure devices: high incidence of peridevice leak and lack of endothelialization

Speaker: Doctor G. Laugaudin (Montpellier, FR)

Access
Abstract
Thumbnail

Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation

Speaker: Professor J. Piccini (Durham, US)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster session 3 - Anticoagulation in atrial fibrillation II

Speakers: Doctor S. Deitelzweig, Doctor E. Ridha, Doctor A. Nissen Bonde, Doctor E. Nguyen, Doctor G. Laugaudin...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb